Bradykinin release following trauma and hemorrhagic shock causes pulmonary alveolar leak in a rodent model
Authors:
- 14 June 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 95 (4) , 558-564
Abstract
BACKGROUND: Hemorrhage accounts for 40% of the preventable death following severe injury. Activation of systemic coagulation produces bradykinin (BK), which may cause leak from the plasma to the extravascular space and to the tissues, which is part of the complex pathophysiology of trauma-induced end-organ injury. We hypothesize that BK, released during activation of coagulation in severe injury, induces pulmonary alveolar leak. METHODS: Isolated neutrophils (PMNs) were pretreated with a specific BK receptor B2 antagonist HOE-140/icatibant and BK priming of the PMN oxidase was completed. Rats underwent tissue injury/hemorrhagic shock (TI/HS), TI/icatibant/HS, and controls (no injury). Evans blue dye was instilled, and the percentage leak from the plasma to the lung was calculated from the bronchoalveolar lavage fluid (BALF). CINC-1 and total protein were measured in the BALF, and myeloperoxidase was quantified in lung tissue. RESULTS: The BK receptor B2 antagonist HOE140/icatibant inhibited (85.0 ± 5.3%) BK priming of the PMN oxidase (p < 0.05). The TI/HS model caused activation of coagulation by increasing plasma thrombin-antithrombin complexes (p < 0.05). Versus controls, the TI/HS rats had significant pulmonary alveolar leak: 1.46 ± 0.21% versus 0.36 ± 0.10% (p = 0.001) and increased total protein and CINC-1 in the BALF (p < 0.05). Icatibant given after the TI significantly inhibited lung leak and the increase in CINC-1 in the BALF from TI/icatibant/HS rats versus TI/HS (p < 0.002 and p < 0.05) but not the total protein. There was no PMN sequestration in the lungs. Conclusions: This mixed injury model caused systemic activation of hemostasis and pulmonary alveolar leak likely due to BK release. CONCLUSION: This mixed injury model caused systemic activation of hemostasis and pulmonary alveolar leak likely due to BK release. LEVEL OF EVIDENCE: Original Article, Basic ScienceKeywords
This publication has 26 references indexed in Scilit:
- Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: Murine Ortholog of the Fletcher TraitThrombosis and Haemostasis, 2012
- Kinin B1 receptor activation turns on exocytosis of matrix metalloprotease-9 and myeloperoxidase in human neutrophils: involvement of mitogen-activated protein kinase familyJournal of Leukocyte Biology, 2009
- Plasma from stored packed red blood cells and MHC class I antibodies causes acute lung injury in a 2-event in vivo rat modelBlood, 2009
- Activation of the Human Contact System on Neutrophil Extracellular TrapsJournal of Innate Immunity, 2009
- Therapeutic potential of icatibant (HOE-140, JE-049)Expert Opinion on Pharmacotherapy, 2008
- Activation of kinin B1 receptors induces chemotaxis of human neutrophilsJournal of Leukocyte Biology, 2006
- Mechanisms underlying the modulatory action of platelet activating factor (PAF) on the upregulation of kinin B1 receptors in the rat pawBritish Journal of Pharmacology, 2003
- Staphylococcus aureus Induces Release of Bradykinin in Human PlasmaInfection and Immunity, 2001
- Plasma and lipids from stored packed red blood cells cause acute lung injury in an animal model.Journal of Clinical Investigation, 1998
- Primed stimulation of isolated perfused rabbit lung by endotoxin and platelet activating factor induces enhanced production of thromboxane and lung injury.Journal of Clinical Investigation, 1990